Similar documents
Malmö Preventive Project. Cardiovascular Endpoints

Cardiovascular Endpoints

Malmö Preventive Project. Cardiovascular Endpoints

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

Cardiovascular Endpoints

Chapter 3: Review of Literature Stroke

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease

APPENDIX A NEUROLOGIST S GUIDE TO USING ICD-9-CM CODES FOR CEREBROVASCULAR DISEASES INTRODUCTION

Hormones and cardiovascular disease, what the Danish Nurse Cohort learned us

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE

International Task Force for Prevention Of Coronary Heart Disease. Clinical management of risk factors. coronary heart disease (CHD) and stroke

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November :38

Statins and Risk for Diabetes Mellitus. Background

Service Specification Template Department of Health, updated June 2015

A Comparison of Hemorrhagic and Ischemic Strokes among Blacks and Whites:

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

GP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre

Critical Illness Supplemental Insurance

Planning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation

Randomized trials versus observational studies

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Lifecheque Basic Critical Illness Insurance

JHS Stroke Program JHS Annual Mandatory Education

NHS outcomes framework and CCG outcomes indicators: Data availability table

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

DIAGNOSTIC CRITERIA OF STROKE

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Policy Perspectives Paper

GENERAL INTRODUCTION

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus

Basic Study Designs in Analytical Epidemiology For Observational Studies

Stroke/VTE Quality Measure Build for Meaningful Use Stage 1

Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου

Bayer Pharma AG Berlin Germany Tel News Release. Not intended for U.S. and UK Media

Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study

Making Sense of the New Statin guidelines. They are more than just lowering your cholesterol!

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

Bayer Extends Clinical Investigation of Xarelto for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer

HITECH Act Update: An Overview of the Medicare and Medicaid EHR Incentive Programs Regulations

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

How To Pay For Critical Illness Insurance From The Ihc Group

Glossary of Methodologic Terms

Early mortality rate (EMR) in Acute Myeloid Leukemia (AML)

Gruppo di lavoro: Malattie Tromboemboliche

Cancer research in the Midland Region the prostate and bowel cancer projects

E x p l a i n i n g Stroke

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

Atherosclerosis of the aorta. Artur Evangelista

Case-Control Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

Thrombophilia. Steven R. Lentz, M.D. Ph.D. Carver College of Medicine The University of Iowa May 2003

Summary Diagnosis and Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in People with Multiple Sclerosis (MS)

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine

Main Effect of Screening for Coronary Artery Disease Using CT

Critical Illness Insurance

Level III Stroke Center Data Collection Requirements

Healthy Aging Lab: Current Research Abstracts

Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism

The author has no disclosures

Risk Factors for Alcoholism among Taiwanese Aborigines

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

LIMITED BENEFIT HEALTH COVERAGE FOR SPECIFIED CRITICAL ILLNESS. OUTLINE OF COVERAGE (Applicable to Policy Form CI-1.0-NC)

New Anticoagulation Options for Stroke Prevention in Atrial Fibrillation. Joy Wahawisan, Pharm.D., BCPS April 25, 2012

The Women s Health Initiative: The Role of Hormonal Therapy in Disease Prevention

Tranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies

Screening Mammography for Breast Cancer: American College of Preventive Medicine Practice Policy Statement

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation

Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium

Critical Illness Insurance

New in Atrial Fibrillation

Cancer and Heart/Stroke coverage

The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT?

A Multi-locus Genetic Risk Score for Abdominal Aortic Aneurysm

Advances in Stroke Care

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention

Research Skills for Non-Researchers: Using Electronic Health Data and Other Existing Data Resources

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Cancer and Heart/Stroke coverage

ESCMID Online Lecture Library. by author

NCCN Prostate Cancer Early Detection Guideline

Quantifying Life expectancy in people with Type 2 diabetes

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

Coronary Heart Disease (CHD) Brief

Anticoagulation at the end of life. Rhona Maclean

The Key Elements of Stroke Rehabilitation: Mark Bayley MD FRCPC

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

Novel Anticoagulation Agents DISCLOSURES. Objectives ATRIAL FIBRILLATION TRIALS. NOAC Comparison 6/12/2015

Hospital-based SNF Coding Tip Sheet: Top 25 codes and ICD-10 Chapter Overview

BREAST CANCER RISK ASSESSMENT AND PRIMARY PREVENTION FOR HIGH RISK PATIENTS, RACHEL CATHERINE JANKOWITZ, MD 1

The New Oral Anticoagulants: When and When Not to Use Them Philip C. Comp, M.D., Ph.D. Professor of Medicine, University of Oklahoma Health Sciences

Transcription:

STROKE April 2011 Dr Amer Jafar

A delay in recognizing early warning signs (WS) and risk factors (RF) of ischemic stroke causes a delay in treatment Evaluated: knowledge of RF and WS and the impact of an educational program by medical students

First surveyed individuals to determine knowledge of WS and RF Then, after a 6-month education program, knowledge was reassessed The authors performed 329 baseline and 355 posteducation surveys Initially, 57.1% mentioned at least 1 RF; this later increased to 65.9%

With regard to WS, 37.6% mentioned at least 1, which increased to 48.1% who mentioned weakness in 1 limb, in half the body, severe headache, and altered vision The educational program was cost-effective and had a positive impact on knowledge of RF and WS of ischemic stroke

Coffee Consumption and Risk of Stroke in Women Coffee consumption has been inconsistently associated with stroke incidence and mortality in previous studies The authors investigated the association between coffee consumption and stroke incidence in the Swedish Mammography Cohort

The authors prospectively followed of 34 670 women without a history of cardiovascular disease or cancer at baseline in 1997 Coffee consumption was assessed in 1997 using a self-administered questionnaire

During a mean follow-up of 10.4 years, we ascertained 1680 stroke events, including 1310 cerebral infarctions, 154 intracerebral hemorrhages, 79 subarachnoid hemorrhages, and 137 unspecified strokes Coffee consumption was associated with a statistically significant lower risk of total stroke, cerebral infarction, and subarachnoid hemorrhage but not intracerebral hemorrhage

These findings suggest that low or no coffee consumption is associated with an increased risk of stroke in women

Adult Cerebral Venous Thrombosis The authors conducted a Comprehensive meta- analysis of all candidate genes studied to assess their genetic contribution to the etiology of CVT Databases were searched to August 2010 for all genes investigated in adult CVT, and odds ratios (ORs) for each gene-disease association were calculated

26 case-control control studies investigating 6 polymorphisms in 6 genes and included 1183 CVT cases and 5189 controls Statistically significant associations with CVT were found for factor V Leiden And prothrombin CVT has a genetic basis

Genes involved in the clotting cascade provide a greater level of thrombosis risk in the cerebral venous circulation compared with its arterial circulation, and a greater level of risk exists for adults compared with children

There is limited information on the influence of ethnicity on functional outcome after stroke A prospective incidence and 6-month outcomes study of all new stroke patients that occurred over 1 year in a defined geographical area in Auckland, New Zealand, during 2002 to 2003

Outcome measures included the Frenchay Activities Index, 36-item Short Form questionnaire, independence, death, composite of death and dependence, and living situation. Functional measures were available in 1127 patients 6 months after stroke

Frenchay Activities Index scores were associated with ethnicity on both univariable and multivariable analysis, with Asian and Pacific people having worse scores Asian people were less likely to be dead compared to Europeans, and Pacific people were more likely to be dependent on others for help than Europeans

Ethnicity was associated independently with functional outcomes The association was attenuated when adjusted for stroke severity and other covariates. The direction of the relationship was not consistent between measures for individual ethnic groups

Statins improve infarct volume and neurological outcome in animal stroke models The authors investigated the relationship between statin therapy and ischemic stroke outcome in the North Dublin Population Stroke Study

population-based prospective cohort study was performed Of 448 ischemic stroke patients, statins were prescribed before stroke onset in 30.1% (134/445) and were begun acutely ( 72 hours) in an additional 42.5% (189/445) Statin therapy at stroke onset and newly begun statins were associated with improved early and late outcomes, supporting data from experimental studies